Pharmacology and the Nursing Process 10th Edition Test Bank - Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific Drugs Related

Review Pharmacology and the Nursing Process 10th Edition Test Bank - Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific Drugs related questions and content

A patient is receiving irinotecan, along with other antineoplastic drugs, as treatment for ovarian cancer. The nurse will monitor for which potentially life-threatening adverse effect that is associated with this drug?

  • A. Severe stomatitis
  • B. Bone marrow suppression
  • C. Delayed-onset cholinergic diarrhea
  • D. Immediate and severe nausea and vomiting
Correct Answer: C

Rationale: In addition to producing hematologic adverse effects, irinotecan has been associated with severe diarrhea, known as cholinergic diarrhea, which may occur during infusions. Delayed diarrhea may occur 2 to 10 days after infusion. It is recommended that this condition can be treated with atropine unless use of that drug is strongly contraindicated. This diarrhea can be severe and even life-threatening.